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Background: Candida species have been associated with the emergence of resistant strains towards selected
antifungal agents. Plant products have been used traditionally as alternative medicine to ease candidal infections.
The present study was undertaken to investigate the antifungal susceptibility patterns and growth inhibiting effect
of Brucea javanica seeds extract against Candida species.
Methods: A total of seven Candida strains that includes Candida albicans ATCC14053, Candida dubliniensis
ATCCMYA-2975, Candida glabrata ATCC90030, Candida krusei ATCC14243, Candida lusitaniae ATCC64125, Candida
parapsilosis ATCC22019 and Candida tropicalis ATCC13803 were used in this study. The antifungal activity, minimum
inhibitory concentration and minimum fungicidal concentration of B. javanica extract were evaluated. Each strain
was cultured in Yeast Peptone Dextrose broth under four different growth environments; (i) in the absence and
presence of B. javanica extract at respective concentrations of (ii) 1 mg/ml (iii) 3 mg/ml and (iv) 6 mg/ml. The
growth inhibitory responses of the candidal cells were determined based on changes in the specific-growth rates
(μ) and doubling time (g). The values in the presence of extract were computed as percentage in the optical
density relative to that of the total cells suspension in the absence of extract.
Results: B. javanica seeds extract exhibited antifungal properties. C. tropicalis showed the highest growth rate;
0.319 ± 0.002 h-1, while others were in the range of 0.141 ± 0.001 to 0.265 ± 0.005 h-1. In the presence of extract, the
lag and log phases were extended and deviated the μ- and g-values. B. javanica extract had significantly reduced
the μ-values of C. dubliniensis, C. krusei and C. parapsilosis at more than 80% (ρ < 0.05), while others were reduced
within the range of 2.28% to 57.05%. The g-values of most candidal strains were extended and significantly reduced
(ρ < 0.05) in relative to the untreated. The candidal population was reduced from an average of 10 x 106 to 6 x
106 CFU/ml.
Conclusions: B. javanica extract exhibited in vitro antifungal activity against seven oral Candida species. The
fungistatic and growth inhibiting effects of B. javanica extract have shown that it has potential to be considered as
a promising candidate for the development of antifungal agent in oral health products.
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In recent years, there has been an increase of reported
cases of oral candidiasis. Less pathogenic strains of
candidal species were found to be associated with oral
candidiasis [1-3]. Although several species Candida
comprise part of the oral commensal microflora, their
emergence may at time cause opportunistic infections
among debilitated and immunocompromised hosts [4,5].
The interactions between candida and the host are ex-
tremely complex. The conversion from commensalism
to parasitism and exuberant growth is usually associated
with intraoral environmental changes and/or a diverse
array of local, systemic and iatrogenic factors. Growth
kinetic is a key virulence factor of most microorganisms
including the Candida species. Candida species have
the ability to grow under diverse environmental condi-
tions. Denture and surfaces of the oral mucosa, for in-
stance, may provide an adequate site for Candida
species to proliferate and establish an infective process.
In the oral ecosystem, substantial change in any key en-
vironmental parameter that affects bacterial growth can
disrupt the natural balance of the microbial component
that may lead to opportunistic infection of the host. The
overgrowth of opportunistic organism such as candida
over other microorganisms can ultimately induce inflam-
mation of the mucosal tissues. This is due to the action
of extracellular enzymes of the growing yeast. Different
species of candida are variably susceptible to drugs even
within the same species, and certain species can develop
resistance to common prescribed antifungal agents [6].
Therefore, an effective antifungal treatment initiated at
an early stage of infection may contribute to better under-
standing of the sustainability of these candidal species.
Recent appearance of Candida species with reduced sus-
ceptibility to antibiotics, and spreading issues concerning
the safety of chemical preservatives and drugs have
prompted researchers to study antimicrobial agents from
natural resources. More than 35,000 plants species are be-
ing used in various human cultures for medical purposes
[7]. There is great demand for agents from natural re-
sources as they are presumed not associated with many
side effects [8-10]. Brucea javanica L. (Simaroubaceae), a
synonym of Brucea amarissima is a plant indigenous to
China, India, Indonesia, Malaysia, Thailand and Vietnam
[11]. The seed and seed oil of this plant have been used in
the treatment of warts and corns. In other countries, the
bark or root bark of B. javanica is a folk remedy for dysen-
tery and verrucous tumor or cancer [12]. It has been re-
ported that B. javanica extract exhibited antiproliferative
and apoptosis-inducing activity on human carcinoma cells
[13]. However, there is a lack of scientific reports that indi-
cate the antifungal activities of B. javanica against oral
Candida species. Hence, this study aimed to investigate
the in vitro antifungal activity of B. javanica aqueousextract against the seven candidal species and the growth
inhibitory response of each Candida species was evaluated
to elicit the efficacy of the extract.Methods
Plant collection and extract preparation
The seeds of Brucea javanica L. were introduced by a col-
league Mr. Zabidi Mohd Majid, obtained from a rural area
in Sekinchan, Selangor. The specimen was scientifically
identified by a botanist and the voucher specimen was de-
posited at the Herbarium of Rimba Ilmu, University of
Malaya. Crude extract of the seeds was prepared accord-
ing to Himratul-Aznita et al. [14]. The seeds (100 g) were
cleaned in running water and oven-dried at 60-65°C for
two days. The dried seeds were homogenized into small
pieces prior to extraction using distilled water at a ratio of
sample to water of 1:10. The homogenate was boiled at
high temperature to one-third of the original volume. The
decoction was filtered through a filter paper (Whatman
No.1) to remove debris before it was further boiled to a
final volume of 100 ml. The decoction was concen-
trated by freeze drying (EYELA FDU-1200, Tokyo)
overnight. The powder obtained was sealed in a sterile
Falcon tube and stored at 4°C. Stock solution of the ex-
tract was prepared in sterile distilled water at concen-
tration of 200 mg/ml. Following centrifugation (Jouan
A14, France) for 10 min at 10,000 rpm, the stock was
then diluted to concentrations required for the experi-
ment. The extract was sterilised by filtration using
0.2 μm nylon syringe filter (Milipore, USA).Preparation of candidal suspension
Seven oral Candida species (Candida albicans ATCC
14053, Candida dubliniensis ATCC MYA-2975, Candida
glabrata ATCC 90030, Candida krusei ATCC 14243,
Candida lusitaniae ATCC 64125, Candida parapsilosis
ATCC 22019 and Candida tropicalis ATCC 13803) used
in this study were purchased from the American Type Cul-
ture Collection (ATCC), USA. These may be a typical rep-
resentative of the species to which it may be assigned. The
candidal stock which was kept frozen in glycerol at −70°C
was thawed at room temperature and then aseptically
dispersed in 5 ml of Yeast Peptone Dextrose (YPD)
broth (BD Difco™) before incubating overnight at 37°C. The
suspensions were then centrifuged at 10,000 rpm (10°C) for
5 min to harvest the cells. The supernatant was discarded
while the pellet was washed twice with sterile saline (NaCl,
8.5 g/L) and then re-suspended in 5 ml of YPD broth. The
turbidity of the suspension was adjusted and standardized
spectrophotometrically to an optical density (OD550nm) of
0.144 which is equivalent to 1 × 106 cells/ml or to #0.5
McFarland standard [14].
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The antifungal activity of the extract was carried out
based on the disc diffusion concept of the Kirby-Bauer
sensitivity test [15]. Sterile blank discs of 6 mm diameter
were impregnated with a concentration of 100 mg/ml.
The discs were air-dried prior to firm placement on the
agar surface which had earlier been seeded with the re-
spective candidal. Throughout this experiment, a blank
disc impregnated with sterile distilled water represented
as negative control while a disc impregnated with a
mouth rinse containing 0.12% w/v chlorhexidine diglu-
conate (CHX) represented as the positive control. The
volume of the test extracts, positive and negative con-
trols impregnated onto the discs were standardized at
100 μl. All plates were incubated overnight at 37°C (except
for C. parapsilosis which required incubation temperature
of 35°C). The susceptibility of candidal species was deter-
mined by the diameter of the growth inhibited zone sur-
rounding the discs. The experiment was carried out three
times in triplicate to ensure reproducibility of observations.Determination of minimum inhibitory concentration (MIC)
Two-fold microdilution broth method was used to deter-
mine the MIC value [16]. The MIC is the lowest concen-
tration of the samples that visually shows absence of
growth. 100 μl of YPD broth was dispensed into wells
marked as Well 1 (W1) to Well 7 (W7). Following this,
100 μl of stock solution (200 mg/ml) was added into W1
and two-fold serial dilution was repeated for W2
through W5. Hence, the final concentrations of B. java-
nica extract in W1, W2, W3, W4 and W5 were 100, 50,
25, 12.5, 6.25 and 3.13 mg/ml, respectively. CHX was
used in place of the plant extract as positive control in
W6, while W7 which only contain the mixture of YPD
broth and the extract represented the negative control.
20 μl of candidal suspension (106 CFU/ml) was added to
W1 through W6, except for W7. Triplicate samples were
performed for each test concentration. The microdilu-
tion plates were incubated overnight at 37°C (except C.
parapsilosis, 35°C). Following this, the growth inhibition
of the candidal cells in microdilution wells was observed.Determination of minimum fungicidal concentration
(MFC)
A standard procedure described by Espinel-Ingroff et al.
[17] was applied to determine the MFC. The MFC cri-
teria value considered in this work was the concentra-
tion where no growth or fewer than three colonies were
obtained to give an approximately 99 to 99.5% killing ac-
tivity. Briefly, 50 μl was taken from the wells of the MIC
assay in which no indication of growth was observed for
all respective Candida species, was sub-cultured onto
fresh YPD agar plates. The plates were incubated at 37°C(C. parapsilosis at 35°C) for 24 to 48 h following which
any visible sign of growth.
Determination of the percentage inhibition of diameter
growth (PIDG)
PIDG provides an indication with regards to the strength
of antifungal activity of the extract in comparison to the
positive control (0.12% w/v CHX). The percentage inhib-
ition of diameter growth (PIDG) values was estimated
according to the equation as below [14]:
PIDG %ð Þ ¼ Diameter of sample‐Diameter of positive control
Diameter of positive control
 100
Growth profiles of Candida species
Five millilitre of candidal suspension (106 cells/ml) was
dispensed into three sterile conical flasks, each contain-
ing 40 ml of YPD broth. 5 ml of sterile distilled water was
added to give a total volume of 50 ml in each flask. The
flasks were incubated at 37°C (C. parapsilosis at 35°C) for
18 h in a shaking water bath to continuously agitate the
suspension. The growth of each species was elucidated by
viable cell counts (CFU enumeration) which were esti-
mated at 2, 6, 10, 14 and 16 h interval. The cell suspen-
sion was first diluted by serial dilution in a nontoxic
diluent (e.g. phosphate-buffered saline, pH 7.2-7.4) be-
fore plating. Spectrophotometric assay [18] which was
based on continuous monitoring of changes in the op-
tical density of cell growth was employed. Cell growth
was measured periodically at every one hour interval
over a period of 18 h at an on optical absorbance of
550 nm. The growth of different candidal species can
be distinguished by measuring the changes of specific-
growth rate (μ) and doubling time (g) following equa-
tions previously described [19,20]:
(i) Specific-growth rate: μ ¼ In Nt=Noð Þt2−t1
(ii) Doubling time: g = log10(Nt/No)/log102
where, Nt represented the number of cells at log phase,
No represented the number of cells at zero time, t2 was
the time taken to reach plateau, and t1 zero time when
the cells enter the log phase. Throughout of the study,
CHX was used in place of the extract as a positive
control.
Growth inhibitory activity of Brucea javanica extract
Brucea javanica extract was prepared into stocks of 10,
30 and 60 mg/ml. Five mililiter of each stock concentra-
tion was dispensed into sterile conical flasks containing
40 ml of YPD broth, followed by 5 ml of the respective
candidal suspension (106 cells/ml) to give a final concen-
tration of 1, 3 and 6 mg/ml of the extract. In a similar
manner, the culture flasks were placed in a shaking
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growth of cells in presence of the extract was measured
periodically at every one hour interval over a period of
18 h. Changes in specific-growth rate (μ) and doubling
time (g) were calculated and the findings were compared
with that of the standard. The inhibitory effect of the ex-
tract was also determined based on viable cell counts.
Statistical analysis
All results were computed and expressed as mean ± stand-
ard deviation (SD) from three determinations performed
in triplicate (n = 9). Statistical analysis was performed
using SPSS software (version 18.0) with analysis of vari-
ance (One-Way ANOVA) and post-hoc test Dunnett’s T3
were used to compare the significant difference between
the groups. A ρ-value of < 0.05 was considered as statisti-
cally significant.
Results
Antifungal activity, MIC and MFC of extract
The diameter of inhibition zone (DIZ), MIC, and MFC
values are presented in Table 1. The DIZ values showed
that B. javanica aqueous extract had a wide range of an-
tifungal activities over the candidal species tested. Of the
seven species, C. dubliniensis was the most sensitive
(DIZ 22.7 ± 1.0 mm) to the extract, whereas the othersTable 1 Antifungal activity (DIZ), MIC and MFC of Brucea








(Mean ± SD) (Mean ± SD) (mg/ml) (mg/ml)
C. albicans 13.8 ± 0.8 13.0 ± 0.2 50 100
ATCC 14053
C. dubliniensis 22.7 ± 1.0 11.1 ± 0.3 3.13 12.5
ATCC MYA-2975
C. glabrata 15.6 ± 1.6 9.0 ± 0.5 25 50
ATCC 90030
C. krusei 12.0 ± 1.3 20.2 ± 0.7 50 100
ATCC 14243
C. lusitaniae 15.1 ± 0.8 12.1 ± 0.4 25 25
ATCC 64125
C. parapsilosis 15.0 ± 0.9 25.0 ± 0.2 25 25
ATCC 22019
C. tropicalis 11.3 ± 1.0 19.3 ± 0.3 50 100
ATCC 13803
aAntifungal activity was evaluated by measuring the diameter of inhibition
zone (DIZ) of the seven candidal species. The concentration of B. javanica
seeds extract was standardised at 100 mg/ml. CHX represents a
positive control.
bValues are determined based on three determinations performed in
triplicate (n = 9).were relatively lower in the range of 11.3 to 15.6 mm. C.
dubliniensis, C. glabrata, C. lusitaniae and C. parapsilosis
were more susceptible to the extract (≥ 15 mm)
whereas C. albicans, C. krusei and C. tropicalis were re-
sistant (< 15 mm). Thus, 15 mm that represented the effect
of the extract on three out of seven Candida species was
used as a breakpoint in this analysis. The other four species
showed extreme deviation from this value. The MIC and
MFC values were ranged from 3.13 to 100 mg/ml. Chlor-
hexidine (CHX)-containing (1.2 mg/ml of 0.12% w/v) mou-
thrinse which used as a reference exhibited clear zones of
inhibition to range between 9.3 to 25.0 mm (MIC and
MFC of 1.87-3% w/v) (Table 1). It is always possible that
the susceptibility of candidal species may not be uni-
form based on its minimum strength to inhibit the can-
didal cells.
Determination of PIDG
Based on the PIDG values obtained for all the seven spe-
cies, C. glabrata, C. dubliniensis, C. lusitaniae and C.
tropicalis were determined susceptible to B. javanica ex-
tract, indicating a high PIDG over the control. The rest
of the candidal species however, showed comparatively
low susceptibility to the extract compared to the control
(Figure 1).
Growth profile of Candida species
Figure 2 displayed the normal growth curves of the
seven candidal species cultured under the normal, un-
treated growth condition. The curves were all sigmoidal,




















Selective concentrations of B. javanica (mg/ml) 
C. albicans C. dubliniensis C. glabrata C. krusei
C. lusitaniae C. parapsilosis C. tropicalis
Figure 1 The PIDGs evaluation which represents the percentage
of inhibition of seven candidal species upon exposure with B.
javanica aqueous extract at respective concentrations of 25, 50,
100 and 200 mg/ml. The values plotted were expressed as mean ±






















C. albicans C. dubliniensis C. glabrata
C. krusei C. lusitaniae C. parapsilosis
C. tropicalis
Figure 2 Normal growth curves of Candida species cultured in
YPD broth media. The cell growth signified by the sigmoidal
growth curve pattern indicating an orderly increase in cell mass and
size. The values are expressed mean ± SD from three independent
experiments performed in triplicate (n = 9).
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observed among the different species. In general, about
5 to 7 h was required by the cells to adapt to the normal
growth environment before they were ready to prolifer-
ate and enter the log phase. C. tropicalis showed the
highest growth rates (0.319 ± 0.002 h-1) indicating high
proliferation. The others were in the range of 0.141 ±
0.001 to 0.265 ± 0.005 h-1. The doubling time of C. dubli-
niensis (3.330 ± 0.164 h) was observed to be slightly longer
than the others which were ranged between 1.816 ±
0.052 h and 2.229 ± 0.037 h. Growth kinetics of the candi-
dal species was also elucidated based on the enumeration
of the colony forming units (CFU) (Figure 3). It is clearly
shown that the population of candidal species was grad-
ually increased from 4.5 × 106 to 10.0 × 106 CFU/ml over
18 h of incubation.Growth inhibitory response of Candida species to Brucea
javanica extract
The pattern of growth curves of the candidal species
were altered and showed deviations from the normal
curves following treatment with B. javanica extract. Re-
duction in cell population was also observed when the
candidal cells were cultured at selected concentrations
(Figure 3). Although each growth phase is affected by
the extract in different ways, the most obvious change
induced by exposure of the candidal cells to with the in-
crease in extract concentration, the growth curves were
observed to shift to the right due to extension of the lag
phases. This effect together with the suppression of cell
growth was indicated by the elevated g-values and re-
duction in μ-values, respectively (Table 2).The growth suppression effect of the extract was
found to be concentration dependent. At 1 mg/ml, the
μ-values of C. parapsilosis, C. krusei, C. dubliniensis and
C. tropicalis were significantly reduced by 87.94%, 88.05%,
86.45% and 57.05%, respectively (ρ < 0.05). At 3 mg/ml,
the μ-values of C. glabrata and C. albicans were reduced
by 17.87% and 50.57%, respectively. At higher concentra-
tion of 6 mg/ml, the μ-values of all candidal species were
further reduced by more than 90% except for C. albicans
(57.41%) (ρ < 0.05). Meanwhile at 1 mg/ml, the extract
causes an increase to the g-values within the range of
0.76-fold to 1.41-fold. At 6 mg/ml however, the g-values
significantly fell within the range of 0.08-fold to 1.28-fold
(ρ < 0.05) compared to the untreated candida. Deviations
in the μ- and g-values had led to extension of the lag and
log phases. Based on CFU enumeration, the cell popula-
tion (CFU/ml) of all species was also reduced from an
average of 10 × 106 to 6 × 106 CFU/ml.
Discussion
Despite fluctuations in the external surroundings that
may affect the unicellular Candida species, these cells
respond differently to adverse environmental conditions
in order to sustain growth. At present, there are serious
efforts to discover compounds with promising antimicro-
bial activities from plants [21,22]. B. javanica extract has
been used externally to treat vaginal trichomoniasis and
various fungal infections [23], also exhibited antiprolifera-
tive activity on human carcinoma cells [13]. In this study,
the extent of antifungal activity of this extract was further
studied on seven species of oral candida. The efficacy of
the extract on the growth profiles of the organisms was
determined based on continuous monitoring of changes
in the optical density of fungal growth over time. Similar
approach was employed to analyze the growth characteris-
tics of various filamentous fungi and oral bacteria [18,24].
High reproducibility and accuracy of the method have
been reported. Sub-minimal inhibitory concentrations
(sub-MICs) were used throughout the experiment to en-
sure that the observed reduced optical absorbance was
not an attribution of cell death.
From the Kirby-Bauer sensitivity test, B. javanica ex-
tract was found to exhibit varying degree of antifungal
activity towards different species of candida. The per-
centage inhibition of radial growth (PIRG) [25] was ap-
plied with some modification. In this in vitro study, the
results were incorporated into the formula for PIDG de-
termination. Based on the percentage plotted in Figure 1,
C. glabrata, C. dubliniensis and followed by C. lusitaniae
were highly affected by the extract of B. javanica which
outstrips the CHX (positive control). This was indicated
by the positive values of PIDG. The PIDG for C. albicans
however outstrips the positive control at high concentra-
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C. tropicalis ATCC 13803 
Figure 3 The population of candidal species under treatment of B. javanica extract at 1 mg/ml (red circle), 3 mg/ml (green circle) and
6 mg/ml (yellow circle). Deviation of cell numbers from the normal (blue circle) indicates the effect of the extract on the growth. CHX was used
as a reference (pink circle). Data are mean ± SD of three independent experiments performed in triplicate (n = 9).
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other candidal species were less affected by the control
and this explains the effectiveness of CHX as a reference
in many clinical trials.
In normal growth condition, the duration of the lag
phase (the period until the first significant change in
OD) of candidal species was ranged from 5 to 7 h indi-
cating that different species in the genus Candida have
different reproducibility. When curves of growth in the
presence of increasing concentrations of B. javanica ex-
tract were studied, both parameters; the doubling time
(g) and specific-growth rates (μ) of seven candidal spe-
cies were affected compared with those of the extract-free (untreated) growth media. The extract exhibited sig-
nificant reduction towards the growth of all seven candi-
dal tested (ρ < 0.05). The g-values of most candidal
species were also extended and reduced by 90%, specific-
ally at concentration of 6 mg/ml. The extended lag
phases strongly suggest that the extract has successfully
suppressed the cells and exerted fungistatic effect on the
candidal species. This indicates that candidal cells grown
in the presence of the extract could experience environ-
mental stress, which could influence its ability to use nu-
trients efficiently and disrupt their normal biological
functions [19]. The need of putative enzymes may also
be suppressed. The cells were not able to grow as
Table 2 Changes in the doubling time (g) and specific-growth rates (μ) of the seven candidal species that cultured in
the absence (untreated) and presence of Brucea javanica extract
Candida
spp.
Doubling time (g) & specific- Untreated Brucea javanica L.
growth rates (μ) 1 mg/ml 3 mg/ml 6 mg/ml
Candida g (h) 2.403 ± 0.095 2.461 ± 0.083 2.727 ± 0.101 3.021 ± 0.094
albicans μ (h-1) 0.263 ± 0.011 0.257 ± 0.008 0.130 ± 0.022 0.112 ± 0.006
Increase in g - 1.02-fold 1.13-fold 1.26-fold
Reduction in μ - 2.28% 50.57% 57.41%
Candida g (h) 3.330 ± 0.164 2.526 ± 0.124 2.096 ± 0.204 0.271 ± 0.016
dubliniensis μ (h-1) 0.251 ± 0.010 0.034 ± 0.012 0.014 ± 0.003 0.002 ± 0.002
Increase in g - 0.76-fold 0.63-fold 0.08-fold
Reduction in μ - 86.45% 94.42% 99.20%
Candida g (h) 2.229 ± 0.037 3.061 ± 0.049 2.543 ± 0.041 2.843 ± 0.177
glabrata μ (h-1) 0.263 ± 0.004 0.249 ± 0.005 0.218 ± 0.004 0.025 ± 0.006
Increase in g - 1.37-fold 1.14-fold 1.28-fold
Reduction in μ - 5.32% 17.11% 90.49%
Candida g (h) 2.542 ± 0.045 3.109 ± 0.241 1.950 ± 0.096 1.024 ± 0.042
krusei μ (h-1) 0.251 ± 0.006 0.030 ± 0.003 0.028 ± 0.002 0.015 ± 0.002
Increase in g - 1.22-fold 0.77-fold 0.40-fold
Reduction in μ - 88.05% 88.84% 94.02%
Candida g (h) 2.694 ± 0.058 3.425 ± 0.111 2.708 ± 0.046 0.867 ± 0.043
lusitaniae μ (h-1) 0.265 ± 0.005 0.238 ± 0.003 0.087 ± 0.005 0.008 ± 0.002
Increase in g - 1.27-fold 1.01-fold 0.32-fold
Reduction in μ - 10.19% 67.17% 96.98%
Candida g (h) 1.816 ± 0.052 1.615 ± 0.108 1.554 ± 0.098 0.614 ± 0.105
parapsilosis μ (h-1) 0.141 ± 0.001 0.017 ± 0.004 0.010 ± 0.002 0.003 ± 0.001
Increase in g - 0.89-fold 0.86-fold 0.34-fold
Reduction in μ - 87.94% 92.91% 97.87%
Candida g (h) 2.809 ± 0.017 3.967 ± 0.089 3.466 ± 0.108 0.568 ± 0.055
tropicalis μ (h-1) 0.319 ± 0.002 0.137 ± 0.003 0.026 ± 0.005 0.005 ± 0.003
Increase in g - 1.41-fold 1.23-fold 0.20-fold
Reduction in μ - 57.05% 91.85% 98.43%
Values were obtained from spectrophotometric assay and expressed as mean ± SD of three independent experiments performed in triplicate (n = 9).
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mined size and volume required to enable them to div-
ide successfully. The cells may deactivate its metabolism
while waiting for the environment to revert back to
normal.
It was shown that the higher extract concentrations,
the longer the lag phase of the growth curves. This effect
was previously observed for candidal species when
growth curves based on capacitance were obtained [26].
The presence of extract decreased the germination and
elongation rates of spores and germinated spores, re-
spectively. Therefore, the critical turbidity was delayed,
resulting in longer lag phases. Upon the addition of B.
javanica extract into the growth environment, the log
phases of candidal species were also reduced. Besides,the internal system of some candidal cells might have
been disrupted by the presence of B. javanica extract
and this clearly explained by the reduction of cell popu-
lation in Figure 3. Considering the candidal species as a
part of the normal flora in human oral cavity, it is ac-
ceptable to allow the yeast cells to grow at minimal rate,
or at least to diminish the overgrowth of candidal spe-
cies over the other microflora.
Conclusion
In conclusion, this study showed that the crude B. java-
nica extracted from the seeds possessed antifungal activ-
ity against the seven candidal species tested. The
efficacious of the extract was elucidated by the growth
inhibitory response and fungistatic activity on candidal
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concentration, indicating the effect is concentration
dependent. This implies that it has potential to be devel-
oped as an alternative of antifungal agent which later
can be applicable in oral health products. Further study
is necessary to access the effects of the extract on oral
mucosal cells. Isolation and characterization of chemical
constituents of the extract would also be necessary to
identify the active component with potential for clinical
use.
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